Sector: Healthcare|Industry: Drug Manufacturers - General|Market Cap: $145.47B|Employees: 26.7K
Amgen Inc. is a leading global biotechnology company focused on discovering, developing, manufacturing, and delivering innovative human therapeutics to treat serious illnesses. The company's primary revenue streams come from the sale of its marketed products, which include Prolia, Enbrel, Otezla, and others. Amgen leverages its expertise in human genetics and protein engineering to address areas of high unmet medical need, maintaining a robust pipeline and a significant market position.
Detailed Profile